These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31802863)

  • 1. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major.
    Mehrizi TZ; Ardestani MS; Khamesipour A; Hoseini MHM; Mosaffa N; Anissian A; Ramezani A
    J Mater Sci Mater Med; 2018 Jul; 29(8):125. PubMed ID: 30056571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney.
    Zadeh Mehrizi T; Shafiee Ardestani M; Haji Molla Hoseini M; Khamesipour A; Mosaffa N; Ramezani A
    Sci Rep; 2018 Aug; 8(1):11759. PubMed ID: 30082741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nano-sized chitosan amphotericin B formulation with considerable improvement against Leishmania major.
    Mehrizi TZ; Ardestani MS; Molla Hoseini MH; Khamesipour A; Mosaffa N; Ramezani A
    Nanomedicine (Lond); 2018 Dec; 13(24):3129-3147. PubMed ID: 30463469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
    Riezk A; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
    Loiseau PM; Pomel S; Croft SL
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32916994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of betulinic acid nanoformulations.
    Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN
    Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials.
    Halder A; Shukla D; Das S; Roy P; Mukherjee A; Saha B
    Cytokine; 2018 Oct; 110():412-415. PubMed ID: 29784509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
    Ribeiro TG; Franca JR; Fuscaldi LL; Santos ML; Duarte MC; Lage PS; Martins VT; Costa LE; Fernandes SO; Cardoso VN; Castilho RO; Soto M; Tavares CA; Faraco AA; Coelho EA; Chávez-Fumagalli MA
    Int J Nanomedicine; 2014; 9():5341-53. PubMed ID: 25429219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
    Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
    Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
    Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
    Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
    Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
    Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
    Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
    Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    Srivari Y; Chatterjee P
    J Microencapsul; 2016 Dec; 33(8):689-701. PubMed ID: 27707051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review Study about the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania from 2010 to 2020.
    Mehrizi TZ; Rezayat SM; Ardestani MS; Shahmabadi HE; Ramezani A
    Curr Drug Deliv; 2021; 18(9):1234-1243. PubMed ID: 33726648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
    Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
    Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
    Valdés K; Morales J; Rodríguez L; Günther G
    Nanomedicine (Lond); 2016 Dec; 11(23):3139-3156. PubMed ID: 27809705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
    Zhou W; Wang Y; Jian J; Song S
    Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.